Literature DB >> 12791748

Acute coronary syndrome: unstable angina and non-ST segment elevation myocardial infarction.

Ever D Grech1, David R Ramsdale.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12791748      PMCID： PMC1126130          DOI： 10.1136/bmj.326.7401.1259

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

Review 1.  Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology.

Authors:  M E Bertrand; M L Simoons; K A Fox; L C Wallentin; C W Hamm; E McFadden; P J de Feyter; G Specchia; W Ruzyllo
Journal:  Eur Heart J       Date:  2000-09       Impact factor: 29.983

2.  The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making.

Authors:  E M Antman; M Cohen; P J Bernink; C H McCabe; T Horacek; G Papuchis; B Mautner; R Corbalan; D Radley; E Braunwald
Journal:  JAMA       Date:  2000-08-16       Impact factor: 56.272

3.  ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina).

Authors:  Eugene Braunwald; Elliott M Antman; John W Beasley; Robert M Califf; Melvin D Cheitlin; Judith S Hochman; Robert H Jones; Dean Kereiakes; Joel Kupersmith; Thomas N Levin; Carl J Pepine; John W Schaeffer; Earl E Smith; David E Steward; Pierre Theroux; Raymond J Gibbons; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Loren F Hiratzka; Alice K Jacobs; Sidney C Smith
Journal:  J Am Coll Cardiol       Date:  2002-10-02       Impact factor: 24.094
  3 in total
  35 in total

1.  Evaluative and discriminative properties of the Portuguese MacNew Heart Disease Health-related Quality of Life Questionnaire.

Authors:  A Leal; C Paiva; S Höfer; J Amado; L Gomes; N Oldridge
Journal:  Qual Life Res       Date:  2005-12       Impact factor: 4.147

2.  An optimal Wilcoxon-Mann-Whitney test of mortality and a continuous outcome.

Authors:  Roland A Matsouaka; Aneesh B Singhal; Rebecca A Betensky
Journal:  Stat Methods Med Res       Date:  2016-12-29       Impact factor: 3.021

3.  Assessment of vascular contrast and wall motion of the aortic root and ascending aorta on MDCT angiography: dual-source high-pitch vs non-gated single-source acquisition schemes.

Authors:  Jared D Christensen; Danielle M Seaman; Matthew P Lungren; Lynne M Hurwitz; Daniel T Boll
Journal:  Eur Radiol       Date:  2014-02-28       Impact factor: 5.315

4.  Tirofiban versus abciximab: tirofiban is administered at suboptimal dosages when evaluated in an arterial thrombosis model in non-human primates.

Authors:  Walter J Janse van Rensburg; Jan P Roodt; Seb Lamprecht; S Muriel Meiring; Philip N Badenhorst
Journal:  Clin Exp Med       Date:  2012-01-05       Impact factor: 3.984

5.  Development of a Series of (1-Benzyl-3-(6-methoxypyrimidin-3-yl)-5-(trifluoromethoxy)-1H-indol-2-yl)methanols as Selective Protease Activated Receptor 4 (PAR4) Antagonists with in Vivo Utility and Activity Against γ-Thrombin.

Authors:  Kayla J Temple; Matthew T Duvernay; Summer E Young; Wandong Wen; Wenjun Wu; Jae G Maeng; Anna L Blobaum; Shaun R Stauffer; Heidi E Hamm; Craig W Lindsley
Journal:  J Med Chem       Date:  2016-08-08       Impact factor: 7.446

6.  Positive psychological states and health behaviors in acute coronary syndrome patients: A qualitative study.

Authors:  Jeff C Huffman; Christina M DuBois; Carol A Mastromauro; Shannon V Moore; Laura Suarez; Elyse R Park
Journal:  J Health Psychol       Date:  2014-08-11

7.  Contributions of Protease-Activated Receptors PAR1 and PAR4 to Thrombin-Induced GPIIbIIIa Activation in Human Platelets.

Authors:  Matthew T Duvernay; Kayla J Temple; Jae G Maeng; Anna L Blobaum; Shaun R Stauffer; Craig W Lindsley; Heidi E Hamm
Journal:  Mol Pharmacol       Date:  2016-10-26       Impact factor: 4.436

8.  Prediction of persistence of combined evidence-based cardiovascular medications in patients with acute coronary syndrome after hospital discharge using neural networks.

Authors:  Valérie Bourdès; Jean Ferrières; Jacques Amar; Elisabeth Amelineau; Stéphane Bonnevay; Maryse Berlion; Nicolas Danchin
Journal:  Med Biol Eng Comput       Date:  2011-05-20       Impact factor: 2.602

9.  Effects of Optimism and Gratitude on Physical Activity, Biomarkers, and Readmissions After an Acute Coronary Syndrome: The Gratitude Research in Acute Coronary Events Study.

Authors:  Jeff C Huffman; Eleanor E Beale; Christopher M Celano; Scott R Beach; Arianna M Belcher; Shannon V Moore; Laura Suarez; Shweta R Motiwala; Parul U Gandhi; Hanna K Gaggin; James L Januzzi
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-12-08

10.  Prevalence and impact of non-cardiovascular comorbidities among older adults hospitalized for non-ST segment elevation acute coronary syndrome.

Authors:  Richard Ofori-Asenso; Ella Zomer; Ken Lee Chin; Peter Markey; Si Si; Zanfina Ademi; Andrea J Curtis; Sophia Zoungas; Danny Liew
Journal:  Cardiovasc Diagn Ther       Date:  2019-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.